Average Ratings 0 Ratings

Total
ease
features
design
support

No User Reviews. Be the first to provide a review:

Write a Review

Average Ratings 0 Ratings

Total
ease
features
design
support

No User Reviews. Be the first to provide a review:

Write a Review

Description

Assessing opportunities in early-stage research and development as well as new product creation necessitates advanced tools that provide both flexibility and clarity, enabling your team to confidently reach informed decisions. DPL Portfolio presents a comprehensive suite of analytical instruments within a user-friendly interface. Implementing DPL Portfolio in your organization is straightforward and manageable. Our proven methodology for implementation has been successfully applied in numerous top-tier organizations, ensuring a swift and hassle-free process. If you have an urgent requirement, DPL Portfolio can be utilized immediately with data sourced from standard Excel files located on a server, and its installation software operates seamlessly on client machines. For those organizations needing enhanced data management capabilities, DPL Portfolio can also be seamlessly integrated with widely-used database systems. This database-driven approach facilitates automated data updates, enhances control over sensitive information, and allows for meticulous tracking of your portfolio's version history, thereby streamlining your overall project management effectively.

Description

At Netcapital, we streamline the process for entrepreneurs to secure funding, allowing you to focus on what you excel at—growing your business. Many of the most promising companies remain off the public markets, and the trend of firms going public is diminishing each year. Consequently, a significant number of investors are missing out on the wealth generated by these private enterprises. An article in Bloomberg View highlights that this phenomenon is part of a broader, long-standing trend with various underlying factors. With Netcapital, you have the opportunity to invest in companies that are not publicly traded. Moreover, you can enhance your alternative investment portfolio by making smaller investments across multiple companies, which is typically challenging to achieve independently. It's essential to remember that most investors should limit their exposure to early-stage companies to a minor fraction of their overall portfolio. Therefore, understanding the inherent risks associated with this form of investing is crucial for making informed decisions and maximizing potential returns.

API Access

Has API

API Access

Has API

Screenshots View All

Screenshots View All

Integrations

Bloomberg

Integrations

Bloomberg

Pricing Details

$10,990 one-time payment
Free Trial
Free Version

Pricing Details

No price information available.
Free Trial
Free Version

Deployment

Web-Based
On-Premises
iPhone App
iPad App
Android App
Windows
Mac
Linux
Chromebook

Deployment

Web-Based
On-Premises
iPhone App
iPad App
Android App
Windows
Mac
Linux
Chromebook

Customer Support

Business Hours
Live Rep (24/7)
Online Support

Customer Support

Business Hours
Live Rep (24/7)
Online Support

Types of Training

Training Docs
Webinars
Live Training (Online)
In Person

Types of Training

Training Docs
Webinars
Live Training (Online)
In Person

Vendor Details

Company Name

Syncopation

Founded

2003

Country

United States

Website

www.syncopation.com/products/dpl-portfolio/

Vendor Details

Company Name

Netcapital

Founded

2014

Country

United States

Website

netcapital.com

Product Features

Project Management

Agile Methodologies
Budget Management
Client Portal
Collaboration Tools
Cost-to-Completion Tracking
Customizable Templates
Gantt Charts
Idea Management
Kanban Board
Milestone Tracking
Portfolio Management
Resource Management
Time & Expense Tracking
Traditional Methodologies

Product Features

Alternatives

BigPicture Reviews

BigPicture

Appfire

Alternatives

next portfolio Reviews

next portfolio

next level consulting
Polaris PPM Reviews

Polaris PPM

Polaris
Clusterix Reviews

Clusterix

innoscripta SE